Petros Pharmaceuticals annual total assets
2020
2021
2022
2023
2024
2025
Petros Pharmaceuticals Total Assets Growth & History (PTPI)
Petros Pharmaceuticals's total assets was $5.2M for fiscal 2025.
View full Petros Pharmaceuticals company overviewPetros Pharmaceuticals annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $5.2M | −$5.5M | −51.45% |
| 2024 | 2024-12-31 | $10.6M | −$23.2M | −68.53% |
| 2023 | 2023-12-31 | $33.8M | $1.4M | +4.24% |
| 2022 | 2022-12-31 | $32.4M | −$35.0M | −51.89% |
| 2021 | 2021-12-31 | $67.4M | −$2.5M | −3.53% |
| 2020 | 2020-12-31 | $69.9M | — | — |
Petros Pharmaceuticals quarterly total assets
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3.5M | −$3.9M | −52.06% |
| Q1 2026 | 2026-03-31 | $4.4M | −$13.2M | −75.04% |
| Q4 2025 | 2025-12-31 | $5.2M | −$5.5M | −51.45% |
| Q3 2025 | 2025-09-30 | $6.1M | −$14.6M | −70.36% |
| Q2 2025 | 2025-06-30 | $7.4M | −$17.8M | −70.61% |
| Q1 2025 | 2025-03-31 | $17.6M | −$12.7M | −41.92% |
| Q4 2024 | 2024-12-31 | $10.6M | −$23.2M | −68.53% |
| Q3 2024 | 2024-09-30 | $20.7M | −$18.2M | −46.82% |
| Q2 2024 | 2024-06-30 | $25.2M | −$3.6M | −12.38% |
| Q1 2024 | 2024-03-31 | $30.3M | −$258,093 | −0.84% |
| Q4 2023 | 2023-12-31 | $33.8M | $1.4M | +4.24% |
| Q3 2023 | 2023-09-30 | $38.9M | $1.2M | +3.23% |
| Q2 2023 | 2023-06-30 | $28.7M | −$22.3M | −43.73% |
| Q1 2023 | 2023-03-31 | $30.6M | −$25.3M | −45.28% |
| Q4 2022 | 2022-12-31 | $32.4M | −$35.0M | −51.89% |
| Q3 2022 | 2022-09-30 | $37.7M | −$14.3M | −27.56% |
| Q2 2022 | 2022-06-30 | $51.0M | −$5.6M | −9.92% |
| Q1 2022 | 2022-03-31 | $55.9M | −$10.3M | −15.55% |
| Q4 2021 | 2021-12-31 | $67.4M | −$2.5M | −3.53% |
| Q3 2021 | 2021-09-30 | $52.0M | — | — |
| Q2 2021 | 2021-06-30 | $56.7M | — | — |
| Q1 2021 | 2021-03-31 | $66.2M | — | — |
| Q4 2020 | 2020-12-31 | $69.9M | — | — |
Petros Pharmaceuticals total assets trends
Over the last five fiscal years, Petros Pharmaceuticals's total assets decreased from $69.9M to $5.2M, a change of −$64.7M. The latest reported quarter, Q2 2026, shows $3.5M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Petros Pharmaceuticals source filings ↗